financetom
Market
financetom
/
Market
/
JPMorgan ditches call to buy Chinese stocks, citing 'Tariff War 2.0' risk
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JPMorgan ditches call to buy Chinese stocks, citing 'Tariff War 2.0' risk
Sep 5, 2024 1:51 AM

LONDON, Sept 5 (Reuters) - JPMorgan has ditched its buy

recommendation on Chinese stocks, warning of the risk of a

second tariff war after November's U.S. election and citing

worries about the country's growth.

The bank downgraded China to "neutral" from "overweight" in

a note on Wednesday and recommended investors add to bets on

countries such as India, Mexico and Saudi Arabia instead.

WHY IT'S IMPORTANT

China's economy is stumbling - by its standards - and the

country is struggling to attract global investors, who have

moved heavily into other emerging markets such as India.

KEY QUOTE

"China equities could see heightened volatility around the

upcoming U.S. elections," JPMorgan analysts, including Pedro

Martins, said in the note.

"The impact of a potential 'Tariff War 2.0' (with tariffs

increasing from 20% to 60%) could be more significant than the

first tariff war."

CONTEXT

China's CSI 300 stock index has fallen more than

40% since hitting a record high in 2021, with the country

increasingly in economic conflict with the United States and

suffering from a property crisis.

Survey data over the weekend showed China's manufacturing

activity sank to a six-month low in August. And

weaker-than-expected second-quarter growth called into question

China's ability to hit its 5% GDP target this year.

BY THE NUMBERS

JPMorgan said U.S. tariffs of 60% on Chinese products, as

Republican presidential candidate Donald Trump has suggested,

may reduce China's GDP growth by two percentage points from its

current forecast of 4% year-on-year in 2025, excluding any

policy responses.

The bank said it now expects full-year growth in 2024 to

come in at 4.6%, below the 5% target.

WHAT'S NEXT

Investors will scrutinise Chinese economic data and hope for

a bigger stimulus response from Beijing than the existing

reductions to borrowing rates. Inflation and trade balance

figures are due next week.

GRAPHIC

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial
Sector Update: Financial
May 12, 2026
03:41 PM EDT, 05/12/2026 (MT Newswires) -- Financial stocks were higher in late Tuesday afternoon trading, with the NYSE Financial Index rising 0.4% and the State Street Financial Select Sector SPDR ETF (XLF) adding 0.9%. The Philadelphia Housing Index was down 1.1%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) was up 0.2%. Bitcoin (BTC-USD) was falling...
Sector Update: Consumer Stocks Mixed Late Afternoon
Sector Update: Consumer Stocks Mixed Late Afternoon
May 12, 2026
03:58 PM EDT, 05/12/2026 (MT Newswires) -- Consumer stocks were mixed late Tuesday afternoon with the State Street Consumer Staples Select Sector SPDR ETF (XLP) rising 1.6% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) falling 1.2%. In sector news, Redbook US same-store sales last week rose 9.6% from a year earlier after a 7.8% increase in...
Sector Update: Tech
Sector Update: Tech
May 12, 2026
03:27 PM EDT, 05/12/2026 (MT Newswires) -- Tech stocks were lower late Tuesday afternoon, with the State Street Technology Select Sector SPDR ETF (XLK) falling 2.2% and the State Street SPDR S&P Semiconductor ETF (XSD) dropping 5.5%. The Philadelphia Semiconductor index declined 5.2%. In corporate news, Alphabet's (GOOGL) Google said Tuesday it is introducing Googlebook, a new category of laptops...
Sector Update: Healthcare
Sector Update: Healthcare
May 12, 2026
03:30 PM EDT, 05/12/2026 (MT Newswires) -- Healthcare stocks advanced late Tuesday afternoon, with the NYSE Healthcare Index and the State Street Healthcare Select Sector SPDR ETF (XLV) each rising 2%. The iShares Biotechnology ETF (IBB) increased 1.2%. In sector news, President Donald Trump said Tuesday that US Food and Drug Administration Commissioner Marty Makary is resigning, Bloomberg reported. In...
Copyright 2023-2026 - www.financetom.com All Rights Reserved